Growth failure in cystic fibrosis : A true need for anabolic agents?

adjuvant therapy; body height; body mass; caloric intake; clinical trial; counseling; cystic fibrosis; diet therapy; editorial; energy expenditure; enzyme activity; esophagitis; forced expiratory volume; growth disorder; human; insulin resistance; intestine obstruction; low fat diet; malabsorption; malnutrition; nutritional status; practice guideline; priority journal; prognosis; protein synthesis; risk assessment; side effect; signal transduction; weight gain; anabolic agent; growth hormone; histamine H2 receptor antagonist; insulin; proton pump inhibitor